News

Riding on its robust performance, HLL Lifecare Limited has paid Rs. 387 Lakhs as dividend to the Government of India for the financial year 2012 – 13.
Dr. M. Ayyappan, Chairman and Managing Director of HLL, presented the dividend cheque to Union Minister for Health and Family Welfare Shri Ghulam Nabi Azad at a function held on 06 September 2013.  
HLL aggregated a record business of Rs.1376.00 Crore during the fiscal 2012 – 13, registering a turnover growth of 36 per cent over the last financial year.
Starting from a single product company has transformed to a total contraceptive company and now to a Healthcare delivery company.
Growth Strategy driven by innovation, HLL Corporate R&D Centre, the 60,000 sq ft state-of-the-art facility started functioning at Akkulam, Thiruvananthapuram in the state of Kerala on 01 January 2013. The key focus area of the research centre will be “Reproductive Health”. The construction of the prestigious Rs 594-crore Integrated Vaccine Complex, implemented by HLL’s subsidiary, HLL Biotech (HBL) at Chengalpett is progressing as per schedule. During last year, the total annual production capacity of condoms touched at 1640 mn Pcs.
The Department of Public Enterprises (DPE) rated the performance of HLL as ‘Excellent’ for the third consecutive year.

HLL’s range of products includes Contraceptives, Hospital products, Pharmaceuticals, Ayurvedic, Vaccines, Personal hygiene products and Diagnostic kits. Its range of services includes Infrastructure Development, Procurement Consultancy and Facility Management. HLL is positioned as a total healthcare solution provider catering to the well-being of the society at large.